EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 20.99 NZD 0.05% Market Closed
Market Cap: NZ$4.3B

P/S

0.3
Current
47%
Cheaper
vs 3-y average of 0.5

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.3
=
Market Cap
NZ$4.7B
/
Revenue
AU$13B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.3
=
Market Cap
NZ$4.7B
/
Revenue
AU$13B

Valuation Scenarios

EBOS Group Ltd is trading below its 3-year average

If P/S returns to its 3-Year Average (0.5), the stock would be worth NZ$39.6 (89% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+2 475%
Average Upside
900%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 0.3 NZ$20.99
0%
3-Year Average 0.5 NZ$39.6
+89%
5-Year Average 0.5 NZ$41.94
+100%
Industry Average 6.9 NZ$540.46
+2 475%
Country Average 2.8 NZ$217.28
+935%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
NZ$4.7B
/
Jan 2026
AU$13B
=
0.3
Current
NZ$4.7B
/
Jun 2026
AU$13.7B
=
0.3
Forward
NZ$4.7B
/
Jun 2027
AU$14.4B
=
0.3
Forward
NZ$4.7B
/
Jun 2028
AU$15.1B
=
0.3
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

Lower than 93% of companies in New Zealand
Percentile
7th
Based on 236 companies
7th percentile
0.3
Low
0 — 1.3
Typical Range
1.3 — 4.2
High
4.2 —
Distribution Statistics
New Zealand
Min 0
30th Percentile 1.3
Median 2.8
70th Percentile 4.2
Max 20.7

EBOS Group Ltd
Glance View

In the sprawling landscape of the Australasian healthcare and animal care markets, EBOS Group Ltd. stands as a towering presence, orchestrating a symphony of operations that span distribution, logistics, and retail. Established decades ago, EBOS has meticulously expanded its footprint to become a vital linchpin in the supply chain of healthcare and animal care products. Understanding its core operations is akin to peering into a well-oiled machine where efficiency reigns supreme. At the heart of EBOS's business model is its distribution segment, which acts as a conduit for pharmaceutical and healthcare products from manufacturers to a diverse range of clients including hospitals, pharmacies, and aged care facilities. This seamless distribution network is supported by state-of-the-art logistics capabilities, enabling the company to ensure timely and reliable delivery of crucial healthcare supplies across the region. Beyond distribution, EBOS has judiciously diversified into animal care and retail, recognizing the intertwining of human and animal welfare in contemporary lifestyles. Its procurement and distribution of veterinary products capitalize on the robust and growing pet care market, which has seen a surge in demand as households increasingly consider pets as part of the family. The company's retail arm, featuring well-known banners like TerryWhite Chemmart, brings it closer to consumers, providing a direct link to end-users and fortifying its revenue streams. By embracing these complementary business segments, EBOS not only ensures a balanced portfolio but also leverages synergies to maximize profit margins. Thus, through a blend of comprehensive distribution networks and strategic retail positions, EBOS Group Ltd. adeptly maneuvers within its markets, translating efficiency and scale into consistent, sustainable growth.

EBO Intrinsic Value
53.35 NZD
Undervaluation 61%
Intrinsic Value
Price NZ$20.99
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett